awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28072004-189493C3-FB24-4125-A088-3844950FC303
Q28072004-189493C3-FB24-4125-A088-3844950FC303
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28072004-189493C3-FB24-4125-A088-3844950FC303
Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer
P2860
Q28072004-189493C3-FB24-4125-A088-3844950FC303
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28072004-189493C3-FB24-4125-A088-3844950FC303
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3f07bb530edbf5a81ba45e2d4fe1eabc56ba2479
P2860
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer